TLR activation pathways in HIV-1-exposed seronegative individuals.
about
Bovine Viral Diarrhea Virus Type 2 Impairs Macrophage Responsiveness to Toll-Like Receptor Ligation with the Exception of Toll-Like Receptor 7Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation.Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.TLR8 regulation of LILRA3 in monocytes is abrogated in human immunodeficiency virus infection and correlates to CD4 counts and virus loads.Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples.Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 InfectionNeither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyHigh Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).The genetic basis of resistance to HIV infection and disease progression.Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication.HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates.A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection.
P2860
Q26700098-76A53514-98B3-4DFA-B021-8889B17ADAE4Q34467932-833CE7B2-B261-48BC-A995-850B39DC468AQ34634401-DA832CCD-4ED8-43D1-9096-6DD8E38F53DFQ34664829-636E393D-01B0-4268-81F1-76532FBC9386Q35012716-E8B7E5A0-489B-42F5-B525-9ABEA21BC4D8Q36679201-A1026A30-B456-4DE2-B7A3-B5BD05649488Q36889962-4B1E9B1B-4853-47CF-BE64-9B2CFEB86CBDQ36900870-6BC016FE-530F-4B1E-9F2C-A6F8F5BBBD10Q36930494-A340AA6D-1B2E-495F-A6DE-5209622EC7CBQ36960922-16BA8CDB-37E0-4D7F-8EA5-A5A50718F36DQ37513027-3E7D2101-8557-4927-A762-E2E45BAB395EQ37637890-F32E19C2-229B-498E-AB5A-D63C90E1570EQ37854081-A4195E82-5A15-461F-84D0-DDD2E6B15082Q38096026-21944487-A2D2-43B9-8F0E-740D24A58A8FQ39717911-7FAF364E-AE86-4B48-A3EB-E1934885D4A1Q40891066-6FCE82BD-75E5-49B3-8F98-FDFEF1D05057Q42257475-1651E9BE-AE1B-4AAA-8102-45CBFA7AF4B3Q47160572-3A92ABAA-1804-4868-8435-ECD7C3B85F58Q47582681-A08431E5-467B-4FA6-BD78-04D95F7FB7B2Q54342518-0CD4C0DB-C65B-4104-B183-134FA9A8FA54
P2860
TLR activation pathways in HIV-1-exposed seronegative individuals.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
TLR activation pathways in HIV-1-exposed seronegative individuals.
@en
TLR activation pathways in HIV-1-exposed seronegative individuals.
@nl
type
label
TLR activation pathways in HIV-1-exposed seronegative individuals.
@en
TLR activation pathways in HIV-1-exposed seronegative individuals.
@nl
prefLabel
TLR activation pathways in HIV-1-exposed seronegative individuals.
@en
TLR activation pathways in HIV-1-exposed seronegative individuals.
@nl
P2093
P50
P356
P1476
TLR activation pathways in HIV-1-exposed seronegative individuals.
@en
P2093
Francesco Mazzotta
Gene M Shearer
Manuela Borelli
Piera Pierotti
Sergio Lo Caputo
Valentina Naddeo
P304
P356
10.4049/JIMMUNOL.0902463
P407
P577
2010-02-01T00:00:00Z